The Focus Group as a Demonstration Technique

Focus group interviews are research techniques, and demonstration projects are Extension techniques. Our title is a little misleading; we are merely proposing that many aspects of focus groups can be used to strengthen demonstrations. We describe a focus group field forestry interview that was described by participants as an outstanding demonstration. This was surprising because our project had no demonstration objective. We discuss four aspects of focus group methodology that might be incorporated into demonstrations in order to enhance educational effectiveness: group dynamics, reversed information flow, enhanced networking opportunity, and increased variables in demonstrations to facilitate more discussion

Known-groups validity of the Patient-Reported Outcomes Measurement Information System (PROMIS®) in adolescents and young adults with special healthcare needs

To examine known-groups validity of the Patient-Reported Outcomes Measurement Information System (PROMIS®) Short Forms (SFs) for adolescents and young adults with special health care needs (SHCN) using data collected from the PROMIS Linking Study

Responsiveness to Change in PROMIS

AbstractObjectiveTo compare the responsiveness to change of the Patient-Reported Outcomes Measurement Information System (PROMIS®) asthma impact, pain interference, fatigue, depressive symptoms, mobility, and peer relationship scales to a legacy scale, the Paediatric Asthma Quality of Life Questionnaire (PAQLQ).MethodsTwo hundred and twenty-nine child-parent dyads from public insurance programs were enrolled. PROMIS pediatric short forms (SFs) and the PAQLQ were used to measure health-related quality of life across four time points (T1–T4) over 2 years. The Asthma Control and Communication Instrument was used to measure the change in asthma control, and the Global Rating of Change (GRC) Index for breathing problems and overall health was used to measure the change in health status. Responsiveness was tested by comparing the changes in health-related quality of life with the changes in asthma control and health status over time using t tests, generalized estimating equations, and relative validity approaches. Magnitudes of the responsiveness between the Pediatric PROMIS and PAQLQ were assessed through statistical significance, Cohen's d effect size (ES), and standardized response mean (SRM).ResultsThe PROMIS asthma impact scale and all PAQLQ scales exhibited significant responsiveness (p'sConclusionsThe PROMIS asthma impact SF indicated similar responsiveness to the PAQLQ scales. Due to its brevity and responsiveness, the PROMIS asthma impact SF is useful for clinical practice or research

Phase-Resolved Infrared H- and K-band Spectroscopy of EF Eridani

We present new phase-resolved H and K-band spectroscopy of the ultra-short period magnetic cataclysmic variable EF Eri in its current, prolonged ``low'' state obtained using NIRI on Gemini-North, and NIRSPEC on Keck II. These new data show that the H-band spectrum of EF Eri appears to be dominated by cyclotron emission during the entire orbital cycle. The {\it K}-band spectrum of EF Eri is likewise dominated by cyclotron emission during most of an orbital period, but near binary phase 0.0, the secondary star spectrum may be visible. We conclude that strong, and highly variable cyclotron emission is responsible for the photometric variation previously reported for EF Eri. The nature of this cyclotron emission is complex: the H-band spectra show that the dominant cyclotron harmonic at phase 0.5 peaks at 1.65 $\mu$m, but at phase 0.0, the harmonic peaks near 1.72 $\mu$m. At phase 0.5, there is another cyclotron feature present that peaks in between the H and K bands (near 1.93 $\mu$m), but at phase 0.0, no such feature is present. These data suggest that cyclotron emission from both poles is occurring.Comment: 23 pages of text, 8 figure

An Improved Transit Measurement for a 2.4 R⊕ Planet Orbiting A Bright Mid-M Dwarf K2–28

We present a new Spitzer transit observation of K2–28b, a sub-Neptune (Rp = 2.45 ± 0.28 R⊕) orbiting a relatively bright (V_(mag) = 16.06, K_(mag) = 10.75) metal-rich M4 dwarf (EPIC 206318379). This star is one of only seven with masses less than 0.2 M⊙ known to host transiting planets, and the planet appears to be a slightly smaller analogue of GJ 1214b (2.85 ± 0.20 R⊕). Our new Spitzerobservations were taken two years after the original K2 discovery data and have a significantly higher cadence, allowing us to derive improved estimates for this planet's radius, semimajor axis, and orbital period, which greatly reduce the uncertainty in the prediction of near future transit times for the James Webb Space Telescope (JWST) observations. We also evaluate the system's suitability for atmospheric characterization with JWST and find that it is currently the only small (<3 R⊕) and cool (<600 K) planet aside from GJ 1214b with a potentially detectable secondary eclipse. We also note that this system is a favorable target for near-infrared radial velocity instruments on larger telescopes (e.g., the Habitable Planet Finder on the Hobby–Eberly Telescope), making it one of only a handful of small, cool planets accessible with this technique. Finally, we compare our results with the simulated catalog of the Transiting Exoplanet Survey Satellite (TESS) and find K2–28b to be representative of the kind of mid-M systems that should be detectable in the TESS sample

Characterizing K2 Candidate Planetary Systems Orbiting Low-Mass Stars II: Planetary Systems Observed During Campaigns 1-7

We recently used near-infrared spectroscopy to improve the characterization of 76 low-mass stars around which K2 had detected 79 candidate transiting planets. 29 of these worlds were new discoveries that had not previously been published. We calculate the false positive probabilities that the transit-like signals are actually caused by non-planetary astrophysical phenomena and reject five new transit-like events and three previously reported events as false positives. We also statistically validate 17 planets (7 of which were previously unpublished), confirm the earlier validation of 22 planets, and announce 17 newly discovered planet candidates. Revising the properties of the associated planet candidates based on the updated host star characteristics and refitting the transit photometry, we find that our sample contains 21 planets or planet candidates with radii smaller than 1.25 R⊕, 18 super-Earths (1.25–2 R⊕), 21 small Neptunes (2–4 R⊕), three large Neptunes (4–6 R⊕), and eight giant planets (>6 R⊕). Most of these planets are highly irradiated, but EPIC 206209135.04 (K2-72e, 1.29^(+0.14)_(-0.13) R⊕), EPIC 211988320.01 (R_p = 2.86^(+0.16)_(-0.15) R⊕), and EPIC 212690867.01 (2.20^(+0.19)_(-0.18) R⊕) orbit within optimistic habitable zone boundaries set by the "recent Venus" inner limit and the "early Mars" outer limit. In total, our planet sample includes eight moderately irradiated 1.5–3 R⊕ planet candidates (F_p ≾ 20 F⊕) orbiting brighter stars (Ks < 11) that are well-suited for atmospheric investigations with the Hubble, Spitzer, and/or James Webb Space Telescopes. Five validated planets orbit relatively bright stars (Kp < 12.5) and are expected to yield radial velocity semi-amplitudes of at least 2 m s^(−1). Accordingly, they are possible targets for radial velocity mass measurement with current facilities or the upcoming generation of red optical and near-infrared high-precision RV spectrographs

Ludwig Koch and the Music of Nature

Ludwig Koch was a pioneer of outside broadcast, natural history recording in the first half of the 20th century. This programme explores his methods, techniques and personality through archive recordings and interviews, and includes attempts t recreating his experiments using modern equipment

Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort

INTRODUCTION: Vascular endothelial growth factor (VEGF) plays a central role in promoting angiogenesis and is over-expressed in breast cancer. At least four polymorphisms in the VEGF gene have been associated with changes in VEGF expression levels: -2578C/A, -1154G/A and -634G/C are all located in the promoter region; and +936C/T is located in the 3'-untranslated region. METHOD: We examined the association between these four VEGF polymorphisms and risk for breast cancer among postmenopausal women in CPS-II (Cancer Prevention Study II) Nutrition Cohort. This cohort was established in 1992 and participants were invited to provide a blood sample between 1998 and 2001. Included in this analysis were 501 postmenopausal women who provided a blood sample and were diagnosed with breast cancer between 1992 and 2001 (cases). Control individuals were 504 cancer-free postmenopausal women matched to the cases with respect to age, race/ethnicity, and date of blood collection (controls). RESULTS: We found no association between any of the polymorphisms examined and overall breast cancer risk. However, associations were markedly different in separate analyses of invasive cancer (n = 380) and in situ cancer (n = 107). The -2578C and -1154G alleles, which are both hypothesized to increase expression of VEGF, were associated with increased risk for invasive breast cancer (odds ratio [OR] 1.46, 95% confidence interval [CI] 1.00–2.14 for -2578 CC versus AA; OR 1.64, 95% CI 1.02–2.64 for -1154 GG versus AA) but they were not associated with risk for in situ cancer. The +936C allele, which is also hypothesized to increase VEGF expression, was not clearly associated with invasive breast cancer (OR 1.21, 95% CI 0.88–1.67 for +936 CC versus TT/CT), but it was associated with reduced risk for in situ cancer (OR 0.59, 95% CI 0.37–0.93 for CC versus TT/CT). The -634 C/G polymorphism was not associated with either invasive or in situ cancer. CONCLUSION: Our findings provide limited support for the hypothesis that the -2578C and -1154G VEGF alleles are associated with increased risk for invasive but not in situ breast cancer in postmenopausal women